Bao L - Search Results

1

Nanoroughened adhesion-based capture of circulating tumor cells with heterogeneous expression and metastatic characteristics.

Chen W, Allen SG, Reka AK, Qian W, Han S, Zhao J, Bao L, Keshamouni VG, Merajver SD, Fu J. Chen W, et al. Among authors: bao l. BMC Cancer. 2016 Aug 8;16:614. doi: 10.1186/s12885-016-2638-x. BMC Cancer. 2016. PMID: 27501846 Free PMC article.

2

Mitogen activated protein kinase pathway is involved in RhoC GTPase induced motility, invasion and angiogenesis in inflammatory breast cancer.

van Golen KL, Bao LW, Pan Q, Miller FR, Wu ZF, Merajver SD. van Golen KL, et al. Among authors: bao lw. Clin Exp Metastasis. 2002;19(4):301-11. doi: 10.1023/a:1015518114931. Clin Exp Metastasis. 2002. PMID: 12090470 Free article.

3

Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma.

van Golen KL, Bao L, Brewer GJ, Pienta KJ, Kamradt JM, Livant DL, Merajver SD. van Golen KL, et al. Among authors: bao l. Neoplasia. 2002 Sep-Oct;4(5):373-9. doi: 10.1038/sj.neo.7900258. Neoplasia. 2002. PMID: 12192595 Free PMC article.

4

Reversion of RhoC GTPase-induced inflammatory breast cancer phenotype by treatment with a farnesyl transferase inhibitor.

van Golen KL, Bao L, DiVito MM, Wu Z, Prendergast GC, Merajver SD. van Golen KL, et al. Among authors: bao l. Mol Cancer Ther. 2002 Jun;1(8):575-83. Mol Cancer Ther. 2002. PMID: 12479217

5

Antiangiogenic tetrathiomolybdate enhances the efficacy of doxorubicin against breast carcinoma.

Pan Q, Bao LW, Kleer CG, Brewer GJ, Merajver SD. Pan Q, et al. Mol Cancer Ther. 2003 Jul;2(7):617-22. Mol Cancer Ther. 2003. PMID: 12883034

6

Tetrathiomolybdate inhibits angiogenesis and metastasis through suppression of the NFkappaB signaling cascade.

Pan Q, Bao LW, Merajver SD. Pan Q, et al. Mol Cancer Res. 2003 Aug;1(10):701-6. Mol Cancer Res. 2003. PMID: 12939395

7

Protein kinase C epsilon is a predictive biomarker of aggressive breast cancer and a validated target for RNA interference anticancer therapy.

Pan Q, Bao LW, Kleer CG, Sabel MS, Griffith KA, Teknos TN, Merajver SD. Pan Q, et al. Cancer Res. 2005 Sep 15;65(18):8366-71. doi: 10.1158/0008-5472.CAN-05-0553. Cancer Res. 2005. PMID: 16166314

8

Targeted disruption of protein kinase C epsilon reduces cell invasion and motility through inactivation of RhoA and RhoC GTPases in head and neck squamous cell carcinoma.

Pan Q, Bao LW, Teknos TN, Merajver SD. Pan Q, et al. Cancer Res. 2006 Oct 1;66(19):9379-84. doi: 10.1158/0008-5472.CAN-06-2646. Cancer Res. 2006. PMID: 17018591 Free PMC article.

9

Preclinical development of a bifunctional cancer cell homing, PKCepsilon inhibitory peptide for the treatment of head and neck cancer.

Bao L, Gorin MA, Zhang M, Ventura AC, Pomerantz WC, Merajver SD, Teknos TN, Mapp AK, Pan Q. Bao L, et al. Cancer Res. 2009 Jul 15;69(14):5829-34. doi: 10.1158/0008-5472.CAN-08-3465. Epub 2009 Jun 30. Cancer Res. 2009. PMID: 19567682 Free PMC article.

10

Pomegranate fruit extract impairs invasion and motility in human breast cancer.

Khan GN, Gorin MA, Rosenthal D, Pan Q, Bao LW, Wu ZF, Newman RA, Pawlus AD, Yang P, Lansky EP, Merajver SD. Khan GN, et al. Integr Cancer Ther. 2009 Sep;8(3):242-53. doi: 10.1177/1534735409341405. Integr Cancer Ther. 2009. PMID: 19815594 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,985 results

Search Page

Filters